logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

TNYA
Tenaya Therapeutics, Inc.
0.75
2 x 0.52
2 x 0.96
bid
ask
+
0.01
0.92%
2 @ 04:00 PM
0.75 +0.00 (0.00%)
Ytd4.76%
1y21.68%
0.72
day range
0.75
0.53
52 week range
2.35
Open0.74Prev Close0.74Low0.72High0.75Mkt Cap161.86M
Vol1.24MAvg Vol3.61MEPS-0.44P/EN/AForward P/E-1.28
Beta2.35Short Ratio2.31Inst. Own73.76%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-1350-d Avg0.77200-d Avg0.981yr Est18.50

TNYA News

benzinga.com
Tenaya Therapeutics Appoints Eric Hyllengren CFO, Effective July 13

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to d

Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
globenewswire.com
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer

Experienced Industry Leader Brings Two Decades of Finance, Strategic and Operational Expertise Exper

benzinga.com
Tenaya Therapeutics Reports New Interim Safety And Efficacy Data From MyPEAK-1 Phase 1b/2 Clinical T

All Evaluable Patients Achieved Improvements in Multiple Hallmarks of MYBPC3-Associated HCMBenefits

benzinga.com
Tenaya Therapeutics To Report New Interim Data From Cohort 1 And 2 Of Ongoing MyPEAK-1 Phase 1b/2 Tr

Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to di